Paper41224331
Suppressive effects on metastasis and tumor growth by the knockout of chemokine receptors in a canine cutaneous lymphoma model.
Kanei T and 7 others. J Vet Med Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Suppressive effects on metastasis and tumor growth by the knockout of chemokine receptors in a canine cutaneous lymphoma model. Papers, record 41224331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41224331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Suppressive effects on metastasis and tumor growth by the knockout of chemokine receptors in a canine cutaneous lymphoma model.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dog Diseases | Major topic |
| Receptors, CCR4 | Major topic |
| Skin Neoplasms | Major topic |
| Receptors, CCR7 | Major topic |
| Lymphoma, T-Cell, Cutaneous | Major topic |
| Animals | |
| Dogs | |
| Mice | |
| Cell Line, Tumor | |
| Female | |
| Cell Proliferation | |
| Disease Models, Animal | |
| Male |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28983988 | Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015). | Vet Dermatol | 2018 | https://conductscience.org/library/papers/28983988 | PubMed |
| 2 | 34866095 | Expression and functional analysis of chemokine receptor 7 in canine lymphoma cell lines. | J Vet Med Sci | 2022 | https://conductscience.org/library/papers/34866095 | PubMed |
| 3 | 26953614 | Canine lymphoma: a review. | Vet Q | 2016 | https://conductscience.org/library/papers/26953614 | PubMed |
| 4 | 30635287 | The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. | Blood | 2019 | https://conductscience.org/library/papers/30635287 | PubMed |
| 5 | 30381015 | Keeping Score: Semiquantitative and Quantitative Scoring Approaches to Genetically Engineered and Xenograft Mouse Models of Cancer. | Vet Pathol | 2019 | https://conductscience.org/library/papers/30381015 | PubMed |
| 6 | 26951331 | Cutaneous epitheliotropic T-cell lymphoma with systemic dissemination in a dog. | J Vet Diagn Invest | 2016 | https://conductscience.org/library/papers/26951331 | PubMed |
| 7 | 10998136 | A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. | J Invest Dermatol | 2000 | https://conductscience.org/library/papers/10998136 | PubMed |
| 8 | 22209203 | Molecular cloning and expression analysis of the canine chemokine receptor CCR9. | Vet Immunol Immunopathol | 2012 | https://conductscience.org/library/papers/22209203 | PubMed |
| 9 | 24590277 | Mechanisms of lymphatic metastasis. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24590277 | PubMed |
| 10 | 33976473 | Databases for technical aspects of immunohistochemistry: 2021 update. | J Toxicol Pathol | 2021 | https://conductscience.org/library/papers/33976473 | PubMed |
| 11 | 17297455 | Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. | Oncogene | 2007 | https://conductscience.org/library/papers/17297455 | PubMed |
| 12 | 20023634 | Real-time imaging reveals the single steps of brain metastasis formation. | Nat Med | 2010 | https://conductscience.org/library/papers/20023634 | PubMed |
| 13 | 16116468 | Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16116468 | PubMed |
| 14 | 32983169 | The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration. | Front Immunol | 2020 | https://conductscience.org/library/papers/32983169 | PubMed |
| 15 | 9169480 | The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9169480 | PubMed |
| 16 | 11825560 | Chemokines and the tissue-specific migration of lymphocytes. | Immunity | 2002 | https://conductscience.org/library/papers/11825560 | PubMed |
| 17 | 14971049 | Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. | Eur J Immunol | 2004 | https://conductscience.org/library/papers/14971049 | PubMed |
| 18 | 29361236 | β-Arrestin-2-Dependent Signaling Promotes CCR4-mediated Chemotaxis of Murine T-Helper Type 2 Cells. | Am J Respir Cell Mol Biol | 2018 | https://conductscience.org/library/papers/29361236 | PubMed |
| 19 | 15109401 | Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants. | BMC Immunol | 2004 | https://conductscience.org/library/papers/15109401 | PubMed |
| 20 | 24923332 | Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma. | Vet Comp Oncol | 2016 | https://conductscience.org/library/papers/24923332 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41224331
GET https://conductscience.org/api/papers/v1/41224331/references?page=2